Thomas Schürpf, Ph.D.Associate Director at Discovery Biology, Scholar Rock, Inc
Agenda Sessions
Inhibition of TGFβ1 Activation with SRK-181 Overcomes Primary Resistance to Checkpoint Inhibition Therapy
On DemandView Session